JP2013544272A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544272A5 JP2013544272A5 JP2013541414A JP2013541414A JP2013544272A5 JP 2013544272 A5 JP2013544272 A5 JP 2013544272A5 JP 2013541414 A JP2013541414 A JP 2013541414A JP 2013541414 A JP2013541414 A JP 2013541414A JP 2013544272 A5 JP2013544272 A5 JP 2013544272A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- mtc
- diluent
- direct compression
- compressed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41816410P | 2010-11-30 | 2010-11-30 | |
| US61/418,164 | 2010-11-30 | ||
| PCT/GB2011/001662 WO2012072977A2 (en) | 2010-11-30 | 2011-11-30 | Compound formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544272A JP2013544272A (ja) | 2013-12-12 |
| JP2013544272A5 true JP2013544272A5 (enrdf_load_stackoverflow) | 2016-06-16 |
| JP6093707B2 JP6093707B2 (ja) | 2017-03-08 |
Family
ID=45418703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013541414A Active JP6093707B2 (ja) | 2010-11-30 | 2011-11-30 | 化合物製剤 |
Country Status (10)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014153444A (ja) * | 2013-02-06 | 2014-08-25 | Konica Minolta Inc | 位相差フィルム、偏光板及び液晶表示装置 |
| PL3487505T3 (pl) | 2016-07-25 | 2023-10-09 | Wista Laboratories Ltd. | Podawanie i dawkowanie diaminofenotiazyn |
| FR3104438B1 (fr) * | 2019-12-12 | 2021-11-19 | Univ Bordeaux | Formulation pour le bleu de methylene et procede |
| WO2023232764A1 (en) | 2022-05-31 | 2023-12-07 | Wista Laboratories Ltd. | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
| WO2024063700A1 (en) | 2022-09-21 | 2024-03-28 | Yin Sze Loh | Oral formulation of diaminophenothiazines and methods of making and using the same in the treatment and/or prevention of diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4880373A (en) | 1988-04-28 | 1989-11-14 | The Upjohn Company | Tablet press |
| JPH0840942A (ja) * | 1994-07-29 | 1996-02-13 | Kanegafuchi Chem Ind Co Ltd | 薬物放出制御製剤 |
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| GB0322756D0 (en) | 2003-09-29 | 2003-10-29 | Univ Aberdeen | Methods of chemical synthesis |
| JP5186212B2 (ja) * | 2004-09-23 | 2013-04-17 | ウィスタ ラボラトリーズ リミテッド | メチルチオニニウム塩化物（ｍｔｃ）などのジアミノフェノチアジニウム化合物を化学合成および精製する方法 |
| DK1799662T3 (da) | 2004-09-23 | 2013-07-15 | Wista Lab Ltd | Fremgangsmåder til kemisk syntese og oprensning af diaminophenothiaziniumforbindelser, herunder methylthioniniumchlorid (MTC) |
| JP2008517022A (ja) * | 2004-10-19 | 2008-05-22 | クルカ， トバルナ ズドラビル， デー．デー．， ノボ メスト | 塩酸ドネペジルを含有する固形薬学的組成物 |
| KR101584674B1 (ko) * | 2005-08-24 | 2016-01-13 | 와이어쓰 엘엘씨 | 바제독시펜 아세테이트 제형 및 이의 제조방법 |
| CA2627695A1 (en) * | 2006-01-05 | 2007-07-19 | Teva Pharmaceutical Industries Ltd. | Dry formulations of aripiprazole |
| ATE478058T3 (de) | 2006-03-29 | 2010-09-15 | Wista Lab Ltd | 3,7-diamino-10h-phenothiazinsalze und ihre verwendung |
| US20080317678A1 (en) * | 2007-06-22 | 2008-12-25 | Szymczak Christopher E | Laser Marked Dosage Forms |
| ES2701089T3 (es) | 2007-10-03 | 2019-02-20 | Wista Lab Ltd | Uso terapéutico de las diaminofenotiazinas |
| US20100280975A1 (en) | 2007-11-05 | 2010-11-04 | Wista Laboratories Ltd. | Systems for clinical trials |
| WO2011036561A2 (en) * | 2009-09-24 | 2011-03-31 | Wis Ta Laboratories Ltd. | Process |
-
2011
- 2011-11-30 JP JP2013541414A patent/JP6093707B2/ja active Active
- 2011-11-30 CA CA2818068A patent/CA2818068C/en active Active
- 2011-11-30 SG SG2013040357A patent/SG190406A1/en unknown
- 2011-11-30 SG SG10201602111VA patent/SG10201602111VA/en unknown
- 2011-11-30 US US13/989,953 patent/US9192611B2/en active Active
- 2011-11-30 CN CN201180057700.9A patent/CN103379901B/zh active Active
- 2011-11-30 EP EP11802119.5A patent/EP2645994B1/en active Active
- 2011-11-30 WO PCT/GB2011/001662 patent/WO2012072977A2/en active Application Filing
- 2011-11-30 MY MYPI2013001934A patent/MY163074A/en unknown
- 2011-11-30 AU AU2011334679A patent/AU2011334679B2/en active Active
- 2011-11-30 ES ES11802119.5T patent/ES2655492T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2015215000B2 (en) | Solid pharmaceutical compositions of androgen receptor antagonists | |
| EP2068839B1 (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
| TWI700100B (zh) | 用於口服投藥之包含依澤替米貝（ｅｚｅｔｉｍｉｂｅ）及羅舒伐他汀（ｒｏｓｕｖａｓｔａｔｉｎ）的複合調配物及其製備方法 | |
| KR20150067153A (ko) | 티카그렐러를 함유하는 고형의 경구용 약학 제제 | |
| US20090018175A1 (en) | Pharmaceutical excipient complex | |
| TW202112376A (zh) | 一種含有布魯頓氏酪胺酸激酶抑制劑的口服固體錠劑及其製備方法 | |
| EP2051694A2 (en) | Pharmaceutical compositions comprising aripiprazole | |
| JP2013544272A5 (enrdf_load_stackoverflow) | ||
| TWI774159B (zh) | 含有托格列淨（Tofogliflozin）之固體製劑及其製造方法 | |
| KR101230178B1 (ko) | 골다공증 예방 또는 치료용 조성물 및 이의 제조방법 | |
| JP2017523149A (ja) | エドキサバンの医薬組成物 | |
| JP2012515739A (ja) | Ｈｃｖポリメラーゼ阻害剤のプロドラッグを含む医薬組成物 | |
| CN108174596A (zh) | 包含8-[(3r)-3-氨基-1-哌啶基]-7-(2-丁炔-1-基)-3,7-二氢-3-甲基-1-[4-甲基-2-喹唑啉基)甲基]-1h-嘌呤-2,6-二酮或其药学上可接受的盐的药物组合物 | |
| WO2015022559A1 (en) | Pharmaceutical composition containing rosuvastatin and ramipril | |
| EP2946771B1 (en) | Water-dispersible tablet formulation comprising deferasirox | |
| JP5755382B2 (ja) | 口腔内崩壊錠 | |
| WO2014119667A1 (ja) | カンデサルタンシレキセチル含有医薬組成物 | |
| CN102423482B (zh) | 复方氨氯地平赖诺普利片的制备方法 | |
| JP7233852B2 (ja) | 変色が抑制された固形製剤 | |
| EP4279075B1 (en) | A pharmaceutical composition comprising elagolix | |
| JP6272328B2 (ja) | カンデサルタンシレキセチル含有製剤 | |
| GR1009619B (el) | Φαρμακευτικη συνθεση που περιεχει ριβαροξαβανη και μεθοδος για την παρασκευη αυτης | |
| WO2014002851A1 (ja) | 固形医薬錠剤およびその製造方法 | |
| WO2015199115A1 (ja) | 経口投与用医薬組成物 | |
| RU2261094C1 (ru) | Твердая лекарственная форма для лечения артериальной гипертензии и способ ее изготовления |